Lewis Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$566K Sell
7,219
-222
-3% -$18.6K 0.88% 29
2023
Q2
$656K Sell
7,441
-100
-1% -$8.61K 0.94% 29
2023
Q1
$608K Sell
7,541
-150
-2% -$12.2K 0.91% 29
2022
Q4
$598K Sell
7,691
-100
-1% -$8.11K 0.92% 30
2022
Q3
$629K Sell
7,791
-138
-2% -$12.4K 0.97% 28
2022
Q2
$712K Sell
7,929
-1
-0% -$101 1.02% 26
2022
Q1
$880K Sell
7,930
-189
-2% -$20K 1% 26
2021
Q4
$840K Buy
+8,119
New +$940K 0.88% 28

Other funds holding MDT

Lewis Capital Management's MDT Position: Q3 2023 in Review

Lewis Capital Management reduced its Medtronic (MDT) stake by 3% in Q3 2023, selling an estimated $18.6K and leaving 7,219 shares worth $566K. The position accounts for 0.88% of the portfolio, ranked #29.

Lewis Capital Management first reported a position in MDT in Q4 2021 and has held it in 8 quarters since. The position peaked at $880K in Q1 2022. 1,971 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • Lewis Capital Management held 7,219 shares of Medtronic worth $566K as of Q3 2023.
  • Lewis Capital Management sold 222 Medtronic shares in Q3 2023, an estimated $18.6K.
  • Medtronic made up 0.88% of Lewis Capital Management's portfolio in Q3 2023, its #29 holding.
  • Lewis Capital Management first reported a position in Medtronic in Q4 2021 and has held it in 8 quarters since.
  • Lewis Capital Management's Medtronic position peaked at $880K in Q1 2022.
  • 1,971 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Lewis Capital Management's 13F filing for Q3 2023, filed 8 Nov 2023.